Unexpected Finding in the Cell’s Power Plant
Credit: National Cancer Institute
Almost all of the cell’s energy is produced in the cell’s own power plant, the mitochondria. The inability of mitochondria to function properly leads to mitochondrial disease, affecting about one in 4 000 individuals. Genetically related mitochondrial diseases generally arise from errors in the expression of encoded proteins in the mitochondrion’s genome.
When the mitochondrial genome is transcribed, long RNA strands are formed. These need to be cut down and processed to release the mature mitochondrial RNAs which are essential for the mitochondrion’s internal protein synthesis. The processing of RNA begins in regions that encode mitochondrial transfer RNAs (tRNAs). Studies of this processing at a molecular level can give important clues about mitochondrial diseases because they are often caused by mutations in tRNA components.
Previous research has shown that cutting at the front end (referred to as the 5´-end) and at the rear end (the 3’-end) of the mitochondrial tRNA strand is catalysed by different components. The mitochondrial protein complex RNase P comprise three components (MRPP1, MRPP2, and MRPP3) that cut the 5´-end of the tRNA, whereas a single protein (ELAC2) cuts the 3´-end of the tRNA.
Several unexpected findings
Researchers at Karolinska Institutet have now found that two of the proteins from the RNase P complex, MRPP1 and MRPP2, surprisingly remain bound to the tRNA even after the initial 5´-processing. Even more surprisingly, these two proteins were also necessary for ELAC2 to cut in the 3´-end of the tRNA. The results explain why mutations in tRNA components that were previously believed to only be important in the initial 5´-processing can also strongly affect 3´-processing and other downstream steps in tRNA maturation.
“This novel functionality of MRPP1 and MRPP2 is important when evaluating both the molecular and physiological effects of the mutations found in patients suffering from mitochondrial disease”, says Martin Hällberg, senior researcher at Karolinska Institutet’s Department of Cell and Molecular Biology and the Centre for Structural Systems Biology (CSSB) in Hamburg who led the study.
This article has been republished from materials provided by the Karolinska Institutet. Note: material may have been edited for length and content. For further information, please contact the cited source.
Reinhard, L., Sridhara, S., & Hällberg, B. M. (2017). The MRPP1/MRPP2 complex is a tRNA-maturation platform in human mitochondria. Nucleic Acids Research. doi:10.1093/nar/gkx902
Improving Poultry Production Through Precision Fertility ManagementNews
Whilst the poultry industry has historically regarded fertility as a physiological problem of some males, on-going research is revealing that this view is misleadingly simplistic. The reality is that variation in fertility is a complex issue because fertility is determined by the interaction of male and female factors at multiple levels.READ MORE
Radiographs of Dolly's Skeleton Show No Signs of Abnormal OsteoarthritisNews
Original concerns that cloning caused early-onset osteoarthritis (OA) in Dolly the sheep are unfounded, say experts at the University of Nottingham and the University of Glasgow.READ MORE
New Simple Test Could Help Cystic Fibrosis Patients Find Best TreatmentNews
In a significant step toward personalized medicine for cystic fibrosis, a minimally-invasive technique shows promise as a fast, inexpensive indicator to help more patients access new treatments.READ MORE
Comments | 0 ADD COMMENT
3rd Annual NGS Data Analysis and Informatics Conference
Feb 08 - Feb 09, 2018
3rd Annual Genome Editing & Engineering Conference
Feb 08 - Feb 09, 2018